Escherichia coli 3-phosphoglycerate dehydrogenase (PGDH) catalyzes the first step in serine biosynthesis, and is allosterically inhibited by serine. Structural studies revealed a homotetramer in which the quaternary arrangement of subunits formed an elongated ellipsoid. Each subunit consisted of three domains: nucleotide, substrate and regulatory. In PGDH, extensive interactions are formed between nucleotide binding domains. A second subunit-subunit interaction occurs between regulatory domains creating an extended b sheet. The serine-binding sites overlap this interface. In these studies, the nucleotide and substrate domains (NSDs) were subcloned to identify changes in both catalytic and physical properties upon removal of a subunitsubunit interface. The NSDs did not vary significantly from PGDH with respect to kinetic parameters with the exception that serine no longer had an effect on catalysis. Temperature dependent dynamic light scattering (DLS) revealed the NSDs aggregated > 5°C before PGDH, indicating decreased stability. DLS and gel filtration studies showed that the truncated enzyme formed a tetramer. This result negated the hypothesis that the removal of the regulatory domain would create an enzyme mimic of the unregulated, closely related dimeric enzymes. Expression of the regulatory domain, to study conformational changes induced by serine binding, yielded a product that by CD spectra contained stable secondary structure. DLS and pulsed field gradient NMR studies of the regulatory domain showed the presence of higher oligomers instead of the predicted dimer. We have concluded that the removal of the regulatory domain is sufficient to eliminate serine inhibition but does not have the expected effect on the quaternary structure.
D-3-Phosphoglycerate dehydrogenase (PGDH) catalyzes the first committed step in the phosphorylated serine biosynthetic pathway. During the PGDH reaction, 3-phosphoglycerate (GriP), a glycolytic intermediate, is oxidized to 3-phosphohydroxypyruvate (PHP) with the concomitant reduction of NAD. The pathway, as a branch point off the glycolysis pathway, is tightly regulated. In prokaryotes and lower plants, an inhibitory feedback loop utilizes serine to allosterically regulate the initial step of the pathway, the PGDH reaction [1] [2] [3] . The serine modulation occurs through rare V max -type effects, and may be contrasted with the more common regulation that directly affects the binding of substrate(s) by altering K m [4] .
PGDH belongs to a family of D-2-hydroxyacid dehydrogenases that includes formate dehydrogenase, D-glycerate dehydrogenase, D-lactate dehydrogenase, erythronate-4-phosphate dehydrogenase, D-2-isocaproate dehydrogenase and vancomycin resistant protein [4] . The family members share % 22% sequence identity and 50% sequence similarity. Among the D-2-hydroxyacid dehydrogenases all members are dimeric with the exception of PGDH, which forms a homotetramer. Crystallographic studies of four enzymes within this family {2nac (formate,dehydrogenase [5] ), 1gdh (D-glycerate dehydrogenase [6] ), 2dld (D-lactate dehydrogenase), 1psd (3-phosphoglycerate dehydrogenase [7, 8] } have revealed a striking similarity in their conformations, except for the additional regulatory domain in PGDH.
The crystal structure of the PGDH:NAD:serine complex [7] is depicted in Fig. 1 and illustrates both the domain and quaternary arrangements. The 222 symmetric tetramer has four binding sites for both serine and NADH. The donutlike appearance of PGDH is similar to the tetrameric form of glycerol kinase [9] , another enzyme that is regulated by V max -type kinetic changes. The interface encompassing adjacent nucleotide binding domains is labeled I, and this subunit:subunit contact is shared among all D-2-hydroxyacid dehydrogenases. The additional regulatory domain forms an important new subunit interface, labeled II. The two serine-binding sites located at each interface are comprised of residues from both subunits. As will be shown in this report, the tetrameric PGDH belongs to a family of dimeric homologues but the differences in quaternary structure are not explained solely by the presence of the regulatory domain. Finally a third proposed interface across the middle of the PGDH toroid near the region labeled III in Fig. 1 contains essentially no intersubunit contacts except through the visible loops, residues 160-195. These symmetrically related loops could form relatively close hydrophobic and charge:charge contacts, reinforcing subunit contacts already stabilized by the interface between nucleotide binding domains.
The conformational similarity between the family members is visible in the stereo-drawing shown in Fig. 2 where a PGDH subunit and a formate dehydrogenase subunit have been overlaid by the method of least-squares. The 44-kDa PGDH subunit is divided as follows: nucleotide binding domain (residues 108-292), substrate binding domain (residues 1-102, 304-318), and regulatory or serine-binding domain (residues 336-410). The interconnecting polypeptide segment, residues 103-108, 293-303, and 319-336, may form hinge-like regions. In fact, the homologous polypeptide segments connecting the nucleotide-and substratebinding domains in the dimeric family members have been shown to have conformational variability [5, 6, 10] . Of equal relevance, but not shown in Fig. 2 , the nucleotide binding domains of PGDH associate into a dimer interface entirely homologous with the quaternary structures of dimeric formate [5] , glycerate [6] and D-lactate dehydrogenase.
Using this well-defined homology, the potential conformational changes associated with the inhibited vs. the active form of PGDH were postulated from the crystal structures of apo-and holo-formate dehydrogenase [5] . These crystal complexes revealed that the active site cleft, formed by nucleotide and substrate binding domains, rotated 7.5°into a more closed conformation when ligand was bound. The constraints of the tetrameric nature of PGDH suggest that a similar rotation of the nucleotide and substrate domains into a more closed conformation at the active site would require additional relaxation of interactions at the regulatory domain interface.
The study of proposed domain movements were examined by subcloning portions of PGDH to look at the contribution of the tetrameric structure to catalysis, stability and potential conformational changes at the serine site upon ligand binding. Several chimers consisting of the nucleotide and substrate domains with variable N-and C-termini were made to resemble counterparts in the 2-hydroxyacid dehydrogenase family. The kinetic properties and oligomeric states of these truncated enzymes were determined and compared to intact PGDH. In addition, the regulatory binding domain, RBD, was subcloned to create a smaller model of the serine-binding pocket that could be manipulated for structural study by NMR and evaluated for conformational changes upon ligand binding.
M A T E R I A L S A N D M E T H O D S
The expression vector, pSAWT containing the serA gene was described previously [11] . The plasmids, pTrc99A and pGEX-2T, were from Pharmacia Biotech. PfuDNA polymerase and the SURE cell line were from Stratagene. The resulting overlay of the two subunits is shown in stereo with formate dehydrogenase in red and PGDH in blue. A stick representation NAD bound to FDH (purple) and PGDH (green) is also shown. The regulatory domain of PGDH is at the top followed by the substrate binding domain and finally the NAD binding domain at the bottom of the figure. The overlay of the two coordinate sets illustrates the close conformational homology between the two enzymes including the positioning of the bound coenzyme. 6 Fig. 1 . Structure of PGDH: a summary of structure and mutations. The cartoon illustrates the crystal structure of the serine-inhibited form of PGDH. Three of the subunits of the homotetramer are colored gray. The fourth subunit shows the three component domains, nucleotidebinding domain (blue), the substrate-binding domain (red) and a regulatory domain (green). Three arrows mark: (I) the nucleotidebinding domain interface, and (II) the tetramer interface formed by the interactions of two regulatory domains and (III) unobserved contact across the middle of the tetramer. The position of two of the four serine molecules is shown by van der Waal's surface at the regulatory interface on the left. Also shown in van der Waal's surfaces, the NAD molecule binds within the active site cleft along the top of the nucleotide domain. The numbers 1-7 on the left indicate the Ca positions of the truncated enzymes. Numbers 1-4 and number 7 describe the NSD enzymes. Specifically, numbers 1 and 2 show the position of the N terminus, residue 7 (the first ordered residue in the crystal structure) and 10, respectively. The blue carbon atoms 3 and 4 indicate residues 314 and 317 at the C-terminus of two of the NSD proteins. Residue 336, used in both the NSD and RBD proteins, is indicated by the green Ca ball. 5 The BLR cell line was from Novagen. Restriction enzymes and ligase came from either Promega or Boehringer Mannheim. Oligonucleotide primers were synthesized by the Microchemical Facility at the University of Minnesota, or out-sourced via this facility. DNA gel purification chemicals were from the Bio-Rad. PCR Cleanup Kit was from Promega. The Microchemical Facility at the University of Minnesota confirmed the sequences of DNA inserts. All other chemicals were from Sigma unless otherwise noted.
Mutagenesis
The nucleotide and substrate domain constructs of residues 1-336 (NSD:336) and 1-317 (NSD:317) were subcloned from the pSAWT vector using common PCR techniques into the pTrc99A vector. The NcoI site at the 5¢ end of the serA gene was conserved and a stop codon and unique XbaI site were introduced at the new 3¢ terminus at residue 336 or 317. The NSD:10-314 and NSD:10-317 mutants were constructed using the Stratagene Quik Change TM mutagenesis kit and the NSD:336:pTrc99A vector as the parental DNA. The RBD:336-410 protein, residues 336-410, was made using the same technique as the NSD constructs, but with a BamHI site introduced at the 5¢ end and a HindIII site at the 3¢ end. The PCR product was ligated into the pGEX-2T vector. All mutant sequences were confirmed by DNA sequencing. ampicillin were grown at 37°C until the optical density at 600 nm reached 0.6-0.8. Protein expression was induced with 1-1.5 mM isopropyl thio-b-D-galactoside (IPTG). After induction cells were grown for % 14 h at 22°C. Cell pellets were resuspended in 50 mM KH 2 PO 4 pH 7.0, 2 mM dithiothreitol, 1 mM EDTA and 0.05% NaN 3 (buffer B) and lysed by sonication. The remainder of the purification protocol has been described previously [11] . Purified protein was concentrated using a Centriprep 10K (Amicon) and dialyzed into buffer B. Protein concentration was determined by Bradford assay and/or UV spectra using an extinction coefficient of 0.67 M
. Protein was stored at 4°C.
RBD:336-410. RBD:336-410 plasmid was transformed into competent BLR cells. Six 1-L flasks of 2 · YT broth plus antibiotic were grown at 37°C to D 600 ¼ 0.6-1.0 and then induced with 1 mM IPTG. Cells were grown for % 14 h at 22°C. The cell pellet was resuspended in STE (10 mM Tris/HCl pH 8.0, 1 mM EDTA, 150 mM NaCl) and incubated on ice with 0.1 mgAEmL )1 lysozyme for 15 min The solution was brought to 5 mM dithiothreitol, 2% (w/v) sarkosyl and sonicated. The mixture was stirred at 4°C for 30 min followed by centrifugation at 10 000 g 1 for 30 min. Polyethyleneamine (0.035%) was added to remove DNA/ RNA, stirred at 4°C for 30 min and then respun for 30 min at 10 000 g. The supernatant was concentrated using an Amicon concentrator with a PM10 membrane (3 kDa cutoff) and dialyzed into NaCl/P i /EDTA (16 mM Na 2 HPO 4 , 4 mM NaH 2 PO 4 , 150 mM NaCl, 1 mM EDTA pH 7.3). The dialyzed lysate was respun to remove particulates and loaded onto a glutathione S-transferase (GST) affinity column (Novagen). The column was washed with 10 column vols NaCl/P i /EDTA and then incubated with 250 U thrombin overnight at room temperature. The cleaved RBD:336-410 was eluted, concentrated using a Centriprep 3K (Amicon), and stored at 4°C. Protein concentration was calculated from UV spectra using an extinction coefficient of 0.47 M )1
AEcm
)1 for RBD:336-410. The identity of the protein was confirmed by N-terminal sequencing of the first 10 residues and amino acid analysis (Microchemical Facility, University of Minnesota, MN, USA).
Kinetic analysis
The steady-state initial rates were determined by following either the reduction of 3-PHP or a-ketoglutarate (a-KG). The reaction was set up with a saturating concentration of NADH (100-200 lM) and varied concentrations of PHP (1-100 lM) or a-KG (10.4-5000 lM) at 25°C. The enzyme concentration for the a-KG studies was 1 lM and 0.1-0.5 lM for the PHP reactions. The assay buffer for the a-KG reactions was 50 mM Tris pH 7.5, 1 mM EDTA and 2 mM dithiothreitol. For the 3-PHP reactions, the Tris concentration was increased to 500 mM. The reaction was initiated by the addition of substrate and the decrease in D 340 monitored for 10-20 s. The initial rates were determined by fitting a linear regression to the curve and calculating the slope using CARY 50 kinetics software. Assays were repeated a minimum of five times. The data were analyzed by Michaelis-Menten or Lineweaver-Burke plots and kinetic parameters derived using the SIGMA PLOT 5.0 software (Jandel Scientific Inc.).
Dynamic light scattering experiments
Dynamic light scattering (DLS) experiments were conducted in Buffer B for PGDH and the NSD proteins. RBD:336-410 experiments were done in NaCl/P i /EDTA. For each concentration measured, the protein was spun at 14 000 g for 10 min and passed through a 0.1-lM filter. A 12-lL sample was equilibrated by a built-in thermostat at 5°C increments. Data were collected with a Protein Solutions DLS system and evaluated with the DYNAPRO V4.0 software. For each temperature 15-20 data points were collected. Mean values were calculated for the DLS parameters. Points that were outside 1 SD were excluded. Data were plotted in SIGMA PLOT 5.0.
Gel filtration experiments
Gel filtration experiments were performed in Buffer B. PGDH (2 mgAEmL ) were run over a Sephacryl S200 (Pharmacia) gel filtration column with both low molecular weight standards (ribonuclease A, 13.7 kDa; chymotrypsinogen A, 25 kDa; ovalbumin, 43 kDa; BSA, 67) (Run 1) and high molecular weight standards (aldolase, 158 kDa; catalase, 232 kDa; ferritin, 440 kDa; thyroglobulin, 669 kDa) (Run 2). Chromatograph profiles were calculated from the absorbance of the fractions at 280 nm for the molecular mass standards and activity measurements for PGDH, NSD:317 and D-LDH.
The molecular weights of PGDH, NSD:317 and D-LDH were calculated from the linear regression of
where V e is the elution volume, V o is the void volume and V t is the total volume] vs. the log of the molecular weight of the standards.
CD RBD:336-410 experiments were performed in NaCl/P i / EDTA. CD spectra were collected on protein (0.722AEmgAE mL )1 ) in the presence or absence of 1 mM serine. A buffer blank was completed for both the buffer and buffer plus 1 mM serine. The spectra were collected on a Jasco 710 instrument at room temperature using a 0.05-mm quartz cell. Spectra were collected from 250 to % 200 nm with eight accumulations. The data were averaged over the accumulations, corrected for the buffer blank and random signals were smoothed using the JASCO software package. Data were exported to SIGMA PLOT 5.0 for analysis.
Pulsed-field gradient NMR
To corroborate the DLS measurements, pulsed-field gradient (PFG)-NMR [12, 13] was used to give an independent determination of the translational diffusion constant (D t ) for the protein RBD:336-410. NMR was carried out in collaboration with the Mayo laboratory at the University of Minnesota. Spectra were collected and analyzed by Shou Lin Chang of the Mayo laboratory. In the PFG-NMR experiment, B o , constant magnetic field, was superimposed twice during a short time interval, d, by an additional inhomogenous gradient (G z ). The result of the two gradient pulses is to create an echo. If no motion or relaxation occurred on the z-axis, the echo would have been identical to the initial signal. However, the observed echo will be attenuated by both relaxation and random motion (diffusion), along the z-axis. The attenuation, A(t) can be described by:
where R(t) is attenuation due to relaxation, c is the magnetogyric ratio, G is the gradient strength, d is the duration of the gradient pulse, and D is the interval between the start of the two gradient pulses. . The data were then fit to the semi-log of the equation above to determine the value of D t . Experiments were conducted at both 10 and 25°C. Protein (%1 mM) was in 50 mM KH 2 PO 4 , pH 6.5, in D 2 O. Serine, when present, was at 1 mM. The experiments were carried out on a Varian UNITY 600 MHz NMR with triple resonance probe and triple axis gradient unit (High Magnetic Field Facility, University of Minnesota).
R E S U L T S A N D D I S C U S S I O N

Nucleotide substrate somains from GriP DH
The preparation of a monodisperse form of PGDH insensitive to the presence of serine but fully active was designed based on a previously determined crystal structure ( Fig. 1) [7] . Removal of the serine-binding domain was predicted to eliminate allosteric inhibition by serine and produce a dimeric enzyme. As shown in the data below, manipulation of PGDHs quaternary structure was far more complicated and it was not possible to obtain a dimeric enzyme. Several variations of the NSD's were developed using the standard PCR technique of introducing a stop codon and unique restriction site at the desired termination point.
NSD:336 (residues 1-336), the first two-domain protein to be made, was soluble and yielded % 5-12 mg per 6 L ferment. However, NSD:336 included a segment of the linker sequence between the substrate and the regulatory domains, and tended to form higher oligomeric species (data not shown). This extended linker may have decreased stability and provide a site of aggregation, and was therefore removed in another form NSD:317 (residues 1-317). NSD:317 was monodisperse in solution and relatively stable (see below), and therefore more amenable to study. Two other two-domain enzymes were also created: NSD:10-314 and NSD:10-317. These forms eliminated the N-terminal segment that was disordered in crystalline PGDH with serine. The recombinant products were largely insoluble and further studies were abandoned.
Kinetic evaluation of NSDs
As conformational changes had been linked to the catalytic activity of both PGDH and formate dehydrogenase (FDH) [5, 14] removal of the regulatory domain was hypothesized to have an effect on the kinetic parameters of PGDH. The steady-state parameters are reported for two of the chimers although our primary focus was NSD:317 because the quaternary structure of this enzyme was definable. The activities of PGDH and NSD:317 were assayed following the reduction of PHP, which occurs % 70-fold faster than the oxidation of GriP [15] , or the alternate substrate, a-KG [16] . Although PHP and a-KG are three-and five-carbon substrates, respectively, the fourth carbon and 5-carboxyl of a-KG are similar to the bulky phosphate group in PHP. The results of the steady-state kinetic studies are summarized in Table 1 . For both the PHP and a-KG assays, substrate inhibition was observed at high concentrations (Fig. 3) , possibly due to the slow release of oxidized cofactor and leading to an abortive complex of substrate/ NAD. The data from the reduction of PHP and a-KG, excluding data exhibiting substrate inhibition, were evaluated by Michaelis-Menten plots to derive K m and V max . Overall the kinetic parameters of the native and NSD enzymes do not vary significantly ( Table 1 ). The K m(PHP) for PGDH agrees well with the value first published by Pizer, 1.2 ± 1 vs. 1.3 lM [15] . The alternative substrate, a-KG, shows an 18-fold increase in K m over PHP and an order of magnitude decrease in V max /K m . The lower catalytic efficiency is consistent with the hypothesis that the 5-carboxyl group in a-KG is not a good substitute for the phosphate group of PHP. However, both NSD:317 and PGDH behave similarly with respect to this pseudosubstrate.
The effect of serine on NSD:317 was also tested. Using saturating concentrations of both substrate and cofactor in the presence and absence of 5 mM serine (IC 50 for native enzyme ¼ 5 lM; [17] ), no change in the initial rate of the catalytic reaction was found (data not shown). Given that the NSD enzymes were not affected by serine, the purity of an enzyme preparation, usually contaminated with wildtype PGDH from Escherichia coli, was routinely determined by assays in the presence and absence of serine. Because the kinetic characteristics of NSD:317 are comparable to those of the native enzyme, the release of the hinged active site from the constraints of the regulatory domain have neither increased nor decreased its catalytic capabilities. This reinforces the supposition that the serine-binding domain evolved solely for regulation, and may explain also why the mammalian forms of the enzyme, although no longer regulated by serine [18] , have not shed the serine-binding domain.
Quaternary structure and stability
As shown in Fig. 1 , the PGDH tetramer has two major types of subunit interfaces. Removal of the subunit contacts formed by the regulatory domains, as in the NSD enzymes, was predicted to result in a dimeric species. DLS results from solutions of NSD:336 at micromolar subunit concentrations indicated that this enzyme formed higher oligomeric species, up to 12-mers (data not shown). The removal of the C-terminal linker region (residues 318-336) in the NSD:317 enzyme alleviated the aggregation problem. An overview of the D t for NSD:317 compared to the native enzyme and the concentration dependence is shown in Fig. 4 . In contrast to NSD:336 protein, this truncated form gave reproducible measurements at 0.5, 1.0 and 2.0 mgAEmL )1 (14.7-58.7 lM). The D t values are slightly larger than those for the native enzyme up to 30°C, consistent with NSD:317 forming a somewhat smaller molecule.
The D t data were analyzed by two different methods, both of which are summarized in the insert to Fig. 4 . Using the Stokes-Einstein equation, D t may be used to calculate the equivalent hydrodynamic radius, R h :
where k is the Boltzman constant, T is the absolute temperature and g is the solvent viscosity. As shown in the inset, D t s of 440 and 520 for PGDH and NSD:317, respectively, lead to R h values of 52 Å and 47 Å . The corresponding molecular weights of PGDH and NSD:317, based upon a spherical model, were 157 and 126 kDa respectively. Given that the subunit molecular mass (m) of NSD:317 is 34 kDa, these results suggested that the truncated enzyme was forming a tetramer instead of the expected dimer.
The second method of evaluating D t makes use of the crystallographic model coordinates of PGDH. If the coordinates are used to determine a prolate ellipsoid of equivalent dimensions, R h , of a comparable sphere may be calculated:
where a and b are the half lengths of the long and short axis of the crystallographic prolate ellipsoid, respectively. The proposed structure of NSD as either a dimer, as expected, or . a tetramer, utilizing contacts of the extended loops across the ellipsoid, were modeled from the PGDH coordinates by removing the regulatory domain. The inset of Fig. 4 summarizes the results of these approximations. The agreement between the observed R h and the R h calculated from the crystallographic ellipsoid is consistent with a tetrameric form of NSD:317. The unexpected results of the DLS experiments suggesting a tetrameric form of the NSD:317 enzyme was confirmed by gel filtration. The chromatographs of PGDH (predicted m 176 kDa) and NSD:317 (predicted dimeric m 68 kDa, predicted tetrameric m 136 kDa) revealed that both enzymes were eluting before the molecular mass standard aldolase (m 158 kDa) (Fig. 5) . In fact, PGDH coeluted with the molecular mass standard catalase (m 232 kDa) at a higher than predicted molecular mass, indicating that the ellipsoidal quaternary structure has affected its elution pattern. To evaluate the oligomeric state of NSD:317 while allowing for the overall shape of the molecule, we compared its elution pattern with that of a known dimeric D-2-hydroxyacid dehydrogenase of similar fold, D-LDH (predicted dimeric m 74 kDa) [19] (1ldh).
The D-LDH elution profile indicates that this enzyme forms both a dimer (majority) and a tetramer [19] , with predicted molecular masses of 74 and 148 kDa, respectively. NSD:317 elutes slightly after the tetrameric form D-LDH but significantly before the dimeric form of D-LDH. The differences in tetrameric molecular mass of D-LDH and NSD:317 may result from D-LDH being slightly larger (subunit m of 37 kDa vs. 34 kDa) or reflect a tighter packing of the tetramer form of NSD:317 leading to a more compact and thus ÔsmallerÕ species. If the elution profiles of the well characterized PGDH, the tetrameric D-LDH and dimeric D-LDH are used to determine a molecular mass standard curve, the mass of NSD:317 would be calculated as 141.8 kDa compared to the predicted tetrameric mass of 136 kDa. Therefore, gel filtration results of nonspherical proteins greatly benefit from evaluation with respect to proteins of known similar folds and quaternary structure. The results of the gel filtration studies are consistent with the DLS data in support of a tetrameric form for NSD:317.
The DLS measurements were also used to evaluate the stability of NSD:317 in comparison to PGDH by monitoring D t as a function of temperature. The D t values for the NSD:317 dropped dramatically above 30°C compared to native enzyme, indicative of formation of a larger species. In addition, the polydispersity, that was negligible below 30°C, rises considerably. The decreased stability of NSD:317 and the length dependence of the C-terminus to determine monodispersity are consistent with the now exposed substrate:regulatory domain contact potentially offering a site of aggregation or preliminary unfolding. As mentioned above, mammalian PGDH retains its regulatory binding domain although it no longer allosterically regulated by serine. Perhaps, the RBD has been retained to increase protein stability and limit aggregation. . Note that the elution of PGDH, NSD:317 and D-LDH were determined by activity measurements to remove ambiguity of elution profiles from absorbance measurements at 280 nm.
Regulatory domain
The regulatory or serine-binding domain of PGDH consists of 76 residues (residues 336-410). In the crystal structure, the subunit-subunit interface at the regulatory domains (II in Fig. 1 ) was shown to consist of an extended b sheet created by adjacent subunits [7] . Serine binding was proposed to increase the interactions at this interface thereby locking the active site into a more open and inactive conformation. The uninhibited form of the enzyme would be more flexible at the interface formed by the regulatory domains allowing more motion at the hinge regions and permitting the active site to close. To allow this conformational flexibility, changes at the interface formed by the regulatory domains were proposed to involve the disruption of the extended b sheet.
To study the effect of serine binding at this subunit interface, we attempted to develop a simple dimer of the regulatory domains. The small size of this domain, 76 residues, would allow for structural studies by NMR or crystallography. However, polypeptides of this molecular weight proved difficult to purify from E. coli extracts, so RBD:336-410 was expressed as a GST fusion protein. After cell lysis, SDS gels indicated that the majority of the target protein was in the resulting insoluble pellet. Addition of a detergent, sarkosyl, solubilized much of the GST-RBD:336-410. RBD:336-410 could be obtained in pure form by chromatography on a glutathione column followed by proteolysis with thrombin to remove the GST tag (data not shown).
Unlike the NSD proteins, RBD:336-410 could not be characterized by a catalytic assay. The chemical identity of this small, purified protein was verified by both amino acid analysis and N-terminal sequencing of the first 10 residues. As the protein was solubilized with detergent, CD measurements were conducted to determine whether stable secondary structure had formed. The CD measurements were completed in the presence and absence of serine. Fig. 6 shows that RBD:336-410 had minima for both b structure (217 nm) and a helix (222 and 208 nm). The addition of serine had no significant effect on the secondary structure. The CD spectra show the presence of secondary structural elements consistent with the intact enzyme.
To determine the oligomeric nature of RBD:336-410, both DLS experiments at 18 and 23°C (0.5 mgAEmL
and PFG-NMR studies in collaboration with the Mayo laboratory at the University of Minnesota were carried out. If RBD:336-410 was dimeric, this would be apparent in the D t and the corresponding R h . The NMR studies would also be useful for determining whether the structure of RBD:336-410 could be solved by NMR. The results of these experiments, shown in Table 2 , indicated that the new protein formed not the expected dimeric species, but a higher oligomeric molecule.
In Table 2 , values of R h are based on the Stokes-Einstein relationship mentioned earlier. The results from the two experimentally independent methods, NMR and DLS, agree within 10%. Furthermore, the data in Table 2 indicate that the addition of serine had no significant effect on the D t values. Given the consistency of the data, taking the overall average appeared justified resulting in an R h of 37 Å . Using a partial specific volume of 0.73 mLAEg
, the molecular mass of the new aggregate would be 42 kDa. With a monomeric molecular mass for RBD:336-410 of 8.1 kDa, the regulatory domain by itself behaves like either a pentamer or a . R h (equivalent sphere) was calculated using the Stokes-Einstein model. hexamer. Because of the inherent shape uncertainties in extrapolating molecular masses from DT, and in spite of the close agreement between the two independent methods, the exact oligomeric state and nature of subunit interactions remains unresolved. The results, however, do clearly indicate that the RBD does not form the expected dimer.
C O N C L U S I O N S
The NSD enzymes were developed as an alternative to the serine regulated native PGDH. Removal of the regulatory domain had little influence on the enzyme's catalytic reaction and kinetic parameters determined from steadystate studies. The largest differences between the native enzyme and the NSD proteins occurred in the stability of the enzymes. The native tetramer retained its predicted DT up to 40°C whereas the NSD protein began to aggregate and/or denature between 30 and 35°C. These results are not surprising as removal of the regulatory or serine-binding domain exposes a surface area that is partially buried in the native tetramer and may be susceptible to aggregation or unfolding. In mammals, serine feedback regulation has been replaced by transcriptional control [18] yet the alignment of sequences from a variety of species indicate that the regulatory domain has been conserved. The retention of the regulatory domain and thus the subunit:subunit interface may provide additional stability to the quaternary structure as is observed in the differences between E. coli PGDH and the NSD enzymes. Mutations within this domain of the human PGDH lead to loss of or lowered serine production without a significant decrease in mRNA production [20] . The work presented here would suggest that stability studies of these clinically characterized mutations may give insight as to the role of the regulatory domain in higher eukaryotes. We predicted that the NSDs would more closely resemble other dimeric D-2-hydroxyacid dehydrogenases. The oligomeric structure of NSD:317 was, instead, a tetramer. From the crystallographic structure of the serine-inhibited enzyme, and some preliminary structural results with a mutant form of PGDH, a model has been formulated. Figure 7A ,B reiterate the subunit contacts of the PGDH-NAD-serine structure and the proposed conformational change upon catalysis or release of inhibition. Given that the tetrameric interface, labeled II in Fig. 7 , had been removed, NSD:317 must have formed a new subunit-subunit interface to remain a tetramer. New structural results from a point mutation, W139G PGDH, have shown the collapse of the ellipsoid with extensive interactions being made between the extended loops (residues 165-190) and the subunits across the toroid [21] . Based upon this new structural data we propose that the NSD:317 enzyme has formed a new, or as yet structurally uncharacterized, tetrameric interface through the interaction of the extended loops (residues 165-190) (Fig. 7C) . Perhaps similar subunit:subunit interactions are important in the uninhibited form of PGDH, in which the active site cleft has adopted a closed conformation. Structural studies to investigate that possibility are currently underway.
The subcloning of the regulatory binding domain offered a unique opportunity to look at conformational changes induced by serine as a subset of the whole enzyme. However, the construct proved poorly soluble unless it was coupled with a fusion protein and solubilized with detergents (sarkosyl). The presence of the secondary structure as assessed by CD spectra suggested that the regulatory domain could fold independently. However, DLS and PFG-NMR experiments clearly showed that the protein aggregated under a variety of conditions. The aggregation tendency coupled with the small size makes this domain particularly difficult to analyze with respect to ligand binding. Nonetheless, the DT values obtained from solutions of RBD were nearly identical whether determined by DLS or NMR. This establishes the usefulness of both methods in studying the hydrodynamic properties and quaternary structures of macromolecules, and demonstrated that the regulatory domains alone form an even more complex quaternary structure.
The new enzymes created by recombinant methods provided a step back in the evolutionary chain. Rather than stringing together multiple functional units we can dissect the contribution of individual domains towards the complex regulation and cooperativity observed within this enzyme system. The role of the tetrameric PGDH evolved to provide a means of regulating serine production within prokaryotes and lower plants. Although at the outset we predicted, based upon PGDH structural data and homologous dimeric enzymes, an easily manipulated oligomeric structure, we were foiled by the complexities of heretofore unrevealed subunit:subunit contacts. Loss of one of the obvious tetrameric interfaces still results in a tetrameric enzyme. We continue our studies of this new subunit contact by looking at the native enzyme and why this interface may be beneficial. 
